Related content

Effect of reboxetine on the pharmacokinetics of lorazepam in healthy volunteers

By Jannuzzo M.G.   Dostert P.   Strolin Benedetti M.   Bosc M.   Renoux A.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 300-301

Elsevier

Access to resources Recommend Favorite

Pharmacokinetics of Reboxetine in Volunteers with Hepatic Impairment

By Tran A.  

Clinical Drug Investigation, Vol. 19, Iss. 6, 2000-06 ,pp. : 473-477

Adis International

Access to resources Recommend Favorite

Enantioselective pharmacokinetics and bioavailability of different racemic -lipoic acid formulations in healthy volunteers

By Dar A.   Shaviv N.J.   Hermann R.   Niebch G.   Borbe H.O.   Fieger-Buschges H.   Ruus P.   Nowak H.   Riethmuller-Winzen H.   Peukert M.   Blume H.  

European Journal of Pharmaceutical Sciences, Vol. 4, Iss. 3, 1996-05 ,pp. : 167-174

Elsevier

Access to resources Recommend Favorite

Evaluation of the Potential Pharmacokinetic/Pharmacodynamic Interaction between Fluoxetine and Reboxetine in Healthy Volunteers

By Fleishaker J.C.  

Clinical Drug Investigation, Vol. 18, Iss. 2, 1999-08 ,pp. : 141-150

Adis International

Access to resources Recommend Favorite

Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers

By Dorani Hassan   Schützer Kajs-Marie   Sarich Troy   Wall Ulrika   Logren Ulrika   Ohlsson Lis   Eriksson Ulf  

European Journal of Clinical Pharmacology, Vol. 63, Iss. 6, 2007-06 ,pp. : 571-581

Springer Publishing Company

Access to resources Recommend Favorite